Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SCOPOLAMINE Cause Electrocardiogram qt prolonged? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Electrocardiogram qt prolonged have been filed in association with SCOPOLAMINE (Scopolamine). This represents 1.0% of all adverse event reports for SCOPOLAMINE.

26
Reports of Electrocardiogram qt prolonged with SCOPOLAMINE
1.0%
of all SCOPOLAMINE reports
0
Deaths
22
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From SCOPOLAMINE?

Of the 26 reports, 22 (84.6%) required hospitalization, and 1 (3.8%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SCOPOLAMINE. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does SCOPOLAMINE Cause?

Off label use (418) Nausea (313) Dizziness (293) Product adhesion issue (254) Drug ineffective (231) Vision blurred (212) Vomiting (201) Product quality issue (189) Mydriasis (180) Product use in unapproved indication (163)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which SCOPOLAMINE Alternatives Have Lower Electrocardiogram qt prolonged Risk?

SCOPOLAMINE vs SCOPOLAMINE HYDROBROMIDE SCOPOLAMINE vs SEBELIPASE ALFA SCOPOLAMINE vs SECNIDAZOLE SCOPOLAMINE vs SECUKINUMAB SCOPOLAMINE vs SELADELPAR LYSINE

Related Pages

SCOPOLAMINE Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged SCOPOLAMINE Demographics